YARROW BIOSCIENCE, INC. Number of Reportable Segments
YARROW BIOSCIENCE, INC. (YARW) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- YARROW BIOSCIENCE, INC. number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment, a 0.00% change year-over-year.
- YARROW BIOSCIENCE, INC. number of reportable segments for the quarter ending 2024-03-31 was 1.00 segment, a 0.00% change year-over-year.
- YARROW BIOSCIENCE, INC. number of reportable segments for the quarter ending 2023-03-31 was 1.00 segment, a 0.00% change year-over-year.
- YARROW BIOSCIENCE, INC. number of reportable segments for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
- YARROW BIOSCIENCE, INC. number of reportable segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- YARROW BIOSCIENCE, INC. number of reportable segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
- YARROW BIOSCIENCE, INC. number of reportable segments for fiscal 2021 was 1.00 segment, a 0.00% change from fiscal 2020.
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 1.00 segment S-4/A · filed 2026-06-03 | |||
| 2025-12-31 | 1.00 segment S-4/A · filed 2026-06-03 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-03-06 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-03-01 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-03-14 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-03-17 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 1.00 segment 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-03-04 | |||
| 2020-09-30 | 1.00 segment 10-Q · filed 2020-11-05 | |||
| 2020-03-31 | 1.00 segment 10-Q · filed 2020-05-11 |
segments
| Period end | Number of Reportable Segments 6 month |
|---|---|
| 2020-06-30 | 1.00 segments 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |